title: Low-dose melphalan in myelodysplastic syndromes: an effective treatment for elderly RAEB-I or II patients?
authors.forename: Zhijian
authors.initials: Z
authors.lastname: Xiao
authors.forename: Liang
authors.initials: L
authors.lastname: Liu
authors.forename: Zefeng
authors.initials: Z
authors.lastname: Xu
authors.forename: Tiejun
authors.initials: T
authors.lastname: Qin
authors.forename: Yue
authors.initials: Y
authors.lastname: Zhang
authors.forename: Tianjiao
authors.initials: T
authors.lastname: Zhang
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000754:Anemia, Refractory, with Excess of Blasts / Q000150:complications / Q000188:drug therapy*; D003582:Cytogenetics; D005260:Female; D006801:Humans; D007621:Karyotyping; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D008558:Melphalan